Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Income from Continuing Operations (2022 - 2023)

Historic Income from Continuing Operations for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$5.2 million.

  • Mainz Biomed's Income from Continuing Operations rose 3670.12% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 34.72%. This contributed to the annual value of -$21.7 million for FY2024, which is 1766.47% up from last year.
  • Per Mainz Biomed's latest filing, its Income from Continuing Operations stood at -$5.2 million for Q4 2023, which was up 3670.12% from -$6.3 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed's Income from Continuing Operations ranged from a high of -$5.2 million in Q4 2023 and a low of -$8.3 million during Q2 2023